Vedolizumab associated haematochezia: A disproportionality analysis in USFDA adverse event reporting system database

被引：0
|
作者：
Bellapu, Anusha [1 ]
Viswam, Subeesh K. [1 ]
Sharma, Vasista [1 ]
Chacko, Stephy T. [1 ]
机构：
[1] MS Ramaiah Univ Appl Sci, Bangalore, Karnataka, India
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
4307
引用
收藏
页码：464 / 464
页数：1
相关论文
共 50 条
  • [1] Novel adverse events of vortioxetine: A disproportionality analysis in USFDA adverse event reporting system database
    Subeesh, Viswam
    Singh, Hemendra
    Maheswari, Eswaran
    Beulah, Elsa
    [J]. ASIAN JOURNAL OF PSYCHIATRY, 2017, 30 : 152 - 156
  • [2] EMPAGLIFLOZIN INDUCED PANCREATITIS: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Sharma, V
    Viswam S, K.
    Ravindra, Reddy N.
    Chacko, S.
    Bellapu, A.
    [J]. VALUE IN HEALTH, 2019, 22 : S592 - S593
  • [3] MEPOLIZUMAB INDUCED MYALGIA: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Chacko, S.
    Viswam, K. S.
    Reddy, Ravindra N.
    Sharma, V
    Bellapu, A.
    [J]. VALUE IN HEALTH, 2019, 22 : S882 - S882
  • [4] BEVACIZUMAB INDUCED PULMONARY EMBOLISM: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Bellapu, A.
    Viswam, K. S.
    Reddy, Ravindra N.
    Chacko, S.
    Sharma, V
    [J]. VALUE IN HEALTH, 2019, 22 : S883 - S884
  • [5] POTENTIAL ASSOCIATION OF REMDESIVIR AND HYPERKALEMIA: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Das, A.
    Vajapu, M.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S172 - S172
  • [6] NOVEL ADVERSE EVENTS OF CGRP RECEPTOR ANTAGONISTS: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Sangnure, A.
    Das, A.
    Sajjan, S.
    Ac, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S372 - S373
  • [7] Immune checkpoint inhibitors induced miller fisher syndrome: A disproportionality analysis in USFDA adverse event reporting system database
    Pawar, Mansi
    Lukose, Lipin
    Viswam, Subeesh K.
    Salim, Mohammed K. T.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 634 - 635
  • [8] VEMURAFENIB INDUCED DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS): A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Reddy, Ravindra N.
    Viswam, K. S.
    Thomas, B. E.
    Bellapu, A.
    Sharma, V
    Chacko, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S613 - S613
  • [9] Novel adverse events of blonanserin: a disproportionality analysis in the FDA Adverse Event Reporting System database
    Subeesh, Viswam
    Singh, Hemendra
    Maheswari, Eswaran
    Beulah, Thomas
    [J]. MINERVA PSICHIATRICA, 2018, 59 (02): : 105 - 110
  • [10] ANTIRETROVIRAL THERAPY AND LACTIC ACIDOSIS: RISK QUANTIFICATION USING DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM
    Viswam, S. K.
    Reddy, Ravindra N.
    Maheswari, E.
    Mudigubba, M. K.
    Bellapu, A.
    Sharma, V
    Chacko, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S662 - S662
12345